We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the ...

Pfizer beats Q2 estimates with $14.7B revenue and $0.78 EPS. Management showed extreme confidence by raising full-year EPS guidance. See more on PFE stock here.

Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.

Drugmaker Pfizer ($PFE) recently shared disappointing news about its experimental drug for sickle cell disease, inclacumab. In a late-stage ...

Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

Many high-yield S&P 500 stocks are risky, but 19 'safer' dividend dogs have strong free cash flow to support payouts and are ...

Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

According to Oxford Languages, “sweat equity” is “an interest or increased value in a property earned from labor toward ...

I’m sure not many remember when typing an essay or story required finger strength and dexterity to use a keyboard ...

Expectations of easing inflation resulted in renewed hopes that the Federal Reserve could potentially cut interest rates as soon as next month. As a result, U.S.

The Colorado River Union High School District governing board on Monday will consider a handful of items at its regularly scheduled governing board meeting.